Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

Novartis in spotlight again over Japan study practices

14.02.2014 / Scripintelligence

The leukemia drug was the subject of a multi-center, investigator-initiated joint study begun in 2012, which aimed to gather information on side-effects in chronic myeloid leukemia (CML) patients receiving it or other tyrosine kinase inhibitors.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: